Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

59 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
DAHANCA 10 - Effect of darbepoetin alfa and radiotherapy in the treatment of squamous cell carcinoma of the head and neck. A multicenter, open-label, randomized, phase 3 trial by the Danish head and neck cancer group.
Overgaard J, Hoff CM, Hansen HS, Specht L, Overgaard M, Lassen P, Andersen E, Johansen J, Andersen LJ, Evensen JF, Alsner J, Grau C. Overgaard J, et al. Among authors: evensen jf. Radiother Oncol. 2018 Apr;127(1):12-19. doi: 10.1016/j.radonc.2018.02.018. Epub 2018 Mar 6. Radiother Oncol. 2018. PMID: 29523409 Clinical Trial.
Associations between skin rash, treatment outcome, and single nucleotide polymorphisms in head and neck cancer patients receiving the EGFR-inhibitor zalutumumab: results from the DAHANCA 19 trial.
Brøndum L, Alsner J, Sørensen BS, Maare C, Johansen J, Primdahl H, Evensen JF, Kristensen CA, Andersen LJ, Overgaard J, Eriksen JG. Brøndum L, et al. Among authors: evensen jf. Acta Oncol. 2018 Sep;57(9):1159-1164. doi: 10.1080/0284186X.2018.1464664. Epub 2018 May 17. Acta Oncol. 2018. PMID: 29771169 Clinical Trial.
DAHANCA 9 - a randomized multicenter study to compare accelerated normo-fractionated radiotherapy with accelerated hyperfractionated radiotherapy in patients with primary squamous cell carcinoma of the head and neck (HNSCC).
Evensen JF, Sand Hansen H, Overgaard M, Johansen J, Andersen LJ, Overgaard J. Evensen JF, et al. Acta Oncol. 2019 Oct;58(10):1502-1505. doi: 10.1080/0284186X.2019.1629012. Epub 2019 Jul 8. Acta Oncol. 2019. PMID: 31282236 Clinical Trial. No abstract available.
Five compared with six fractions per week of conventional radiotherapy of squamous-cell carcinoma of head and neck: DAHANCA 6 and 7 randomised controlled trial.
Overgaard J, Hansen HS, Specht L, Overgaard M, Grau C, Andersen E, Bentzen J, Bastholt L, Hansen O, Johansen J, Andersen L, Evensen JF. Overgaard J, et al. Among authors: evensen jf. Lancet. 2003 Sep 20;362(9388):933-40. doi: 10.1016/s0140-6736(03)14361-9. Lancet. 2003. PMID: 14511925 Clinical Trial.
Prevalence and peak incidence of acute and late normal tissue morbidity in the DAHANCA 6&7 randomised trial with accelerated radiotherapy for head and neck cancer.
Mortensen HR, Overgaard J, Specht L, Overgaard M, Johansen J, Evensen JF, Andersen LJ, Andersen E, Grau C. Mortensen HR, et al. Among authors: evensen jf. Radiother Oncol. 2012 Apr;103(1):69-75. doi: 10.1016/j.radonc.2012.01.002. Epub 2012 Mar 5. Radiother Oncol. 2012. PMID: 22398313 Clinical Trial.
Impact of HPV-associated p16-expression on radiotherapy outcome in advanced oropharynx and non-oropharynx cancer.
Lassen P, Primdahl H, Johansen J, Kristensen CA, Andersen E, Andersen LJ, Evensen JF, Eriksen JG, Overgaard J; Danish Head and Neck Cancer Group (DAHANCA). Lassen P, et al. Among authors: evensen jf. Radiother Oncol. 2014 Dec;113(3):310-6. doi: 10.1016/j.radonc.2014.11.032. Epub 2014 Nov 26. Radiother Oncol. 2014. PMID: 25544647 Free article.
Neoadjuvant chemotherapy with cisplatin and 5-fluorouracil in advanced squamous cell carcinoma of the head and neck: a randomized phase III study.
Lewin F, Damber L, Jonsson H, Andersson T, Berthelsen A, Biörklund A, Blomqvist E, Evensen JF, Hansen HS, Hansen O, Jetlund O, Mercke C, Modig H, Overgaard M, Rosengren B, Tausjö J, Ringborg U. Lewin F, et al. Among authors: evensen jf. Radiother Oncol. 1997 Apr;43(1):23-8. doi: 10.1016/s0167-8140(97)01922-1. Radiother Oncol. 1997. PMID: 9165133 Clinical Trial.
59 results